Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 69

1.

Yeast lipids from cardoon stalks, stranded driftwood and olive tree pruning residues as possible extra sources of oils for producing biofuels and biochemicals.

Tasselli G, Filippucci S, Borsella E, D'Antonio S, Gelosia M, Cavalaglio G, Turchetti B, Sannino C, Onofri A, Mastrolitti S, De Bari I, Cotana F, Buzzini P.

Biotechnol Biofuels. 2018 May 23;11:147. doi: 10.1186/s13068-018-1142-8. eCollection 2018.

2.

Soil Selenium (Se) Biofortification Changes the Physiological, Biochemical and Epigenetic Responses to Water Stress in Zea mays L. by Inducing a Higher Drought Tolerance.

Bocchini M, D'Amato R, Ciancaleoni S, Fontanella MC, Palmerini CA, Beone GM, Onofri A, Negri V, Marconi G, Albertini E, Businelli D.

Front Plant Sci. 2018 Mar 27;9:389. doi: 10.3389/fpls.2018.00389. eCollection 2018.

3.

Determination of changes in the concentration and distribution of elements within olive drupes (cv. Leccino) from Se biofortified plants, using laser ablation inductively coupled plasma mass spectrometry.

D'Amato R, Petrelli M, Proietti P, Onofri A, Regni L, Perugini D, Businelli D.

J Sci Food Agric. 2018 Mar 25. doi: 10.1002/jsfa.9030. [Epub ahead of print]

PMID:
29577309
4.

Neural respiratory drive and cardiac function in patients with obesity hypoventilation syndrome following initiation of non-invasive ventilation.

Onofri A, Patout M, Kaltsakas G, Lhuillier E, Mushemi-Blake S, Arbane G, Pengo MF, Marino P, Steier J.

J Thorac Dis. 2018 Jan;10(Suppl 1):S135-S143. doi: 10.21037/jtd.2017.12.129.

5.

Impact of phosphoinositide-3-kinase and vitamin D3 nuclear receptor single-nucleotide polymorphisms on the outcome of malignant melanoma patients.

Morgese F, Soldato D, Pagliaretta S, Giampieri R, Brancorsini D, Torniai M, Rinaldi S, Savini A, Onofri A, Scarpelli M, Berardi R.

Oncotarget. 2017 May 30;8(44):75914-75923. doi: 10.18632/oncotarget.18304. eCollection 2017 Sep 29.

6.

Experimental design matters for statistical analysis: how to handle blocking.

Jensen SM, Schaarschmidt F, Onofri A, Ritz C.

Pest Manag Sci. 2018 Mar;74(3):523-534. doi: 10.1002/ps.4773. Epub 2017 Dec 7.

PMID:
29064623
7.

Biofortification (Se): Does it increase the content of phenolic compounds in virgin olive oil (VOO)?

D'Amato R, Proietti P, Onofri A, Regni L, Esposto S, Servili M, Businelli D, Selvaggini R.

PLoS One. 2017 Apr 27;12(4):e0176580. doi: 10.1371/journal.pone.0176580. eCollection 2017.

8.

Changes in the Fusarium Head Blight Complex of Malting Barley in a Three-Year Field Experiment in Italy.

Beccari G, Prodi A, Tini F, Bonciarelli U, Onofri A, Oueslati S, Limayma M, Covarelli L.

Toxins (Basel). 2017 Mar 29;9(4). pii: E120. doi: 10.3390/toxins9040120.

9.

Study of Holtermanniella wattica, Leucosporidium creatinivorum, Naganishia adeliensis, Solicoccozyma aeria, and Solicoccozyma terricola for their lipogenic aptitude from different carbon sources.

Filippucci S, Tasselli G, Scardua A, Di Mauro S, Cramarossa MR, Perini D, Turchetti B, Onofri A, Forti L, Buzzini P.

Biotechnol Biofuels. 2016 Nov 28;9:259. doi: 10.1186/s13068-016-0672-1. eCollection 2016.

10.

Hyponatremia normalization as an independent prognostic factor in patients with advanced non-small cell lung cancer treated with first-line therapy.

Berardi R, Santoni M, Newsom-Davis T, Caramanti M, Rinaldi S, Tiberi M, Morgese F, Torniai M, Pistelli M, Onofri A, Bower M, Cascinu S.

Oncotarget. 2017 Apr 4;8(14):23871-23879. doi: 10.18632/oncotarget.13372.

11.

Characterization of basidiomycetous yeasts in hypersaline soils of the Urmia Lake National Park, Iran.

Mokhtarnejad L, Arzanlou M, Babai-Ahari A, Di Mauro S, Onofri A, Buzzini P, Turchetti B.

Extremophiles. 2016 Nov;20(6):915-928. Epub 2016 Oct 21.

PMID:
27770301
12.

Hormonal receptors in lung adenocarcinoma: expression and difference in outcome by sex.

Berardi R, Morgese F, Santinelli A, Onofri A, Biscotti T, Brunelli A, Caramanti M, Savini A, De Lisa M, Ballatore Z, Pompili C, Salati M, Mazzanti P, Torniai M, Cascinu S.

Oncotarget. 2016 Dec 13;7(50):82648-82657. doi: 10.18632/oncotarget.12244.

13.

Economic sustainability of anti-PD-1 agents nivolumab and pembrolizumab in cancer patients: Recent insights and future challenges.

Tartari F, Santoni M, Burattini L, Mazzanti P, Onofri A, Berardi R.

Cancer Treat Rev. 2016 Jul;48:20-4. doi: 10.1016/j.ctrv.2016.06.002. Epub 2016 Jun 7. Review.

PMID:
27310708
14.

Risk of Hyponatraemia in Cancer Patients Treated with Targeted Therapies: A Systematic Review and Meta-Analysis of Clinical Trials.

Berardi R, Santoni M, Rinaldi S, Nunzi E, Smerilli A, Caramanti M, Morgese F, Torniai M, Savini A, Fiordoliva I, Onofri A, Pistelli M, Taccaliti A, Cascinu S.

PLoS One. 2016 May 11;11(5):e0152079. doi: 10.1371/journal.pone.0152079. eCollection 2016. Review.

15.

Effects of two different probiotics on microflora, morphology, and morphometry of gut in organic laying hens.

Forte C, Acuti G, Manuali E, Casagrande Proietti P, Pavone S, Trabalza-Marinucci M, Moscati L, Onofri A, Lorenzetti C, Franciosini MP.

Poult Sci. 2016 Nov 1;95(11):2528-2535. Epub 2016 May 3.

PMID:
27143778
16.

Clinical and ultrastructural spectrum of diffuse lung disease associated with surfactant protein C mutations.

Peca D, Boldrini R, Johannson J, Shieh JT, Citti A, Petrini S, Salerno T, Cazzato S, Testa R, Messina F, Onofri A, Cenacchi G, Westermark P, Ullmann N, Cogo P, Cutrera R, Danhaive O.

Eur J Hum Genet. 2016 May;24(5):780. doi: 10.1038/ejhg.2016.12. No abstract available.

17.

Clinical and pathologic predictors of clinical outcome of malignant pleural mesothelioma.

Berardi R, Fiordoliva I, De Lisa M, Ballatore Z, Caramanti M, Morgese F, Savini A, Rinaldi S, Torniai M, Tiberi M, Ferrini C, Onofri A, Cascinu S.

Tumori. 2016 Mar-Apr;102(2):190-5. doi: 10.5301/tj.5000418. Epub 2016 Feb 12.

PMID:
26893272
18.

Gastrointestinal neuroendocrine tumors: Searching the optimal treatment strategy--A literature review.

Berardi R, Rinaldi S, Torniai M, Morgese F, Partelli S, Caramanti M, Onofri A, Polenta V, Pagliaretta S, Falconi M, Cascinu S.

Crit Rev Oncol Hematol. 2016 Feb;98:264-74. doi: 10.1016/j.critrevonc.2015.11.003. Epub 2015 Nov 10. Review.

PMID:
26643525
19.

Impact of VEGF, VEGFR, PDGFR, HIF and ERCC1 gene polymorphisms on thymic malignancies outcome after thymectomy.

Berardi R, Brunelli A, Pagliaretta S, Paolucci V, Conti A, Goteri G, Refai M, Pompili C, Marcantognini G, Morgese F, Ballatore Z, Savini A, De Lisa M, Caramanti M, Santoni M, Zizzi A, Piva F, Mazzanti P, Onofri A, Sabbatini A, Scarpelli M, Cascinu S.

Oncotarget. 2015 Aug 7;6(22):19305-15.

20.

Clinical and ultrastructural spectrum of diffuse lung disease associated with surfactant protein C mutations.

Peca D, Boldrini R, Johannson J, Shieh JT, Citti A, Petrini S, Salerno T, Cazzato S, Testa R, Messina F, Onofri A, Cenacchi G, Westermark P, Ullmann N, Cogo P, Cutrera R, Danhaive O.

Eur J Hum Genet. 2015 Aug;23(8):1033-41. doi: 10.1038/ejhg.2015.45. Epub 2015 Mar 18. Erratum in: Eur J Hum Genet. 2016 May;24(5):780. Ullman, Nicola [corrected to Ullmann, Nicola].

21.

Hyponatremia is a predictor of hospital length and cost of stay and outcome in cancer patients.

Berardi R, Caramanti M, Castagnani M, Guglielmi S, Marcucci F, Savini A, Morgese F, Rinaldi S, Ferrini C, Tiberi M, Torniai M, Rovinelli F, Fiordoliva I, Onofri A, Cascinu S.

Support Care Cancer. 2015 Oct;23(10):3095-101. doi: 10.1007/s00520-015-2683-z. Epub 2015 Mar 5.

PMID:
25739755
22.

Locally advanced rectal cancer: the importance of a multidisciplinary approach.

Berardi R, Maccaroni E, Onofri A, Morgese F, Torniai M, Tiberi M, Ferrini C, Cascinu S.

World J Gastroenterol. 2014 Dec 14;20(46):17279-87. doi: 10.3748/wjg.v20.i46.17279. Review.

23.

Chromium exposure and germinal embryonal carcinoma: first two cases and review of the literature.

Berardi R, Pellei C, Valeri G, Pistelli M, Onofri A, Morgese F, Caramanti M, Mirza RM, Santoni M, De Lisa M, Savini A, Ballatore Z, Giuseppetti GM, Cascinu S.

J Toxicol Environ Health A. 2015;78(1):1-6. doi: 10.1080/15287394.2015.958416. Review.

PMID:
25424542
24.

HLA antigenic and haplotype frequencies estimated in hematopoietic progenitor cell donors from Argentina.

Perusco A, Gamba C, Galarza P, Rojas F, Kalapodis A, Onofri A, Soratti C, Piccinelli G.

Transplant Proc. 2014 Nov;46(9):3064-7. doi: 10.1016/j.transproceed.2014.07.029.

PMID:
25420823
25.

Increased rates of local complication of central venous catheters in the targeted anticancer therapy era: a 2-year retrospective analysis.

Berardi R, Rinaldi S, Santini D, Vincenzi B, Giampieri R, Maccaroni E, Marcucci F, Francoletti M, Onofri A, Lucarelli A, Pierantoni C, Tonini G, Cascinu S.

Support Care Cancer. 2015 May;23(5):1295-302. doi: 10.1007/s00520-014-2466-y. Epub 2014 Oct 19.

PMID:
25326782
26.

Hyponatraemia is a predictor of clinical outcome for malignant pleural mesothelioma.

Berardi R, Caramanti M, Fiordoliva I, Morgese F, Savini A, Rinaldi S, Torniai M, Tiberi M, Ferrini C, Castagnani M, Rovinelli F, Onofri A, Cascinu S.

Support Care Cancer. 2015 Mar;23(3):621-6. doi: 10.1007/s00520-014-2398-6. Epub 2014 Aug 21.

PMID:
25142706
27.

Neurophysiological correlates of eye movement desensitization and reprocessing sessions: preliminary evidence for traumatic memories integration.

Farina B, Imperatori C, Quintiliani MI, Castelli Gattinara P, Onofri A, Lepore M, Brunetti R, Losurdo A, Testani E, Della Marca G.

Clin Physiol Funct Imaging. 2015 Nov;35(6):460-8. doi: 10.1111/cpf.12184. Epub 2014 Aug 15.

PMID:
25123377
28.

Aberrant EEG functional connectivity and EEG power spectra in resting state post-traumatic stress disorder: a sLORETA study.

Imperatori C, Farina B, Quintiliani MI, Onofri A, Castelli Gattinara P, Lepore M, Gnoni V, Mazzucchi E, Contardi A, Della Marca G.

Biol Psychol. 2014 Oct;102:10-7. doi: 10.1016/j.biopsycho.2014.07.011. Epub 2014 Jul 18.

PMID:
25046862
29.

Thymic neoplasms: an update on the use of chemotherapy and new targeted therapies. A literature review.

Berardi R, De Lisa M, Pagliaretta S, Onofri A, Morgese F, Savini A, Ballatore Z, Caramanti M, Santoni M, Mazzanti P, Cascinu S.

Cancer Treat Rev. 2014 May;40(4):495-506. doi: 10.1016/j.ctrv.2013.11.003. Epub 2013 Nov 26. Review.

PMID:
24355362
30.

Opposite behavior of plasma levels surfactant protein type B and receptor for advanced glycation end products in pulmonary sarcoidosis.

Magrì D, Mariotta S, Banfi C, Ricotta A, Onofri A, Ricci A, Pisani L, Cauti FM, Ghilardi S, Agostoni P.

Respir Med. 2013 Oct;107(10):1617-24. doi: 10.1016/j.rmed.2013.07.019. Epub 2013 Aug 13.

31.

Influence of abiotic variables on culturable yeast diversity in two distinct Alpine glaciers.

Turchetti B, Goretti M, Branda E, Diolaiuti G, D'Agata C, Smiraglia C, Onofri A, Buzzini P.

FEMS Microbiol Ecol. 2013 Nov;86(2):327-40. doi: 10.1111/1574-6941.12164. Epub 2013 Jul 2.

32.

Novel small molecule EGFR inhibitors as candidate drugs in non-small cell lung cancer.

Berardi R, Santoni M, Morgese F, Ballatore Z, Savini A, Onofri A, Mazzanti P, Pistelli M, Pierantoni C, De Lisa M, Caramanti M, Pagliaretta S, Pellei C, Cascinu S.

Onco Targets Ther. 2013 May 21;6:563-76. doi: 10.2147/OTT.S28155. Print 2013.

33.

Immune tolerance induced using plasma exchange and rituximab in an infantile Pompe disease patient.

Deodato F, Ginocchio VM, Onofri A, Grutter G, Germani A, Dionisi-Vici C.

J Child Neurol. 2014 Jun;29(6):850-4. doi: 10.1177/0883073813485819. Epub 2013 Apr 25.

PMID:
23620524
34.

State of the art for cardiotoxicity due to chemotherapy and to targeted therapies: a literature review.

Berardi R, Caramanti M, Savini A, Chiorrini S, Pierantoni C, Onofri A, Ballatore Z, De Lisa M, Mazzanti P, Cascinu S.

Crit Rev Oncol Hematol. 2013 Oct;88(1):75-86. doi: 10.1016/j.critrevonc.2013.02.007. Epub 2013 Mar 21. Review.

PMID:
23522920
35.

Role of maspin in cancer.

Berardi R, Morgese F, Onofri A, Mazzanti P, Pistelli M, Ballatore Z, Savini A, De Lisa M, Caramanti M, Rinaldi S, Pagliaretta S, Santoni M, Pierantoni C, Cascinu S.

Clin Transl Med. 2013 Mar 7;2(1):8. doi: 10.1186/2001-1326-2-8.

36.

NT-proatrial natriuretic peptide as a possible biomarker of cardiopulmonary involvement in sarcoidosis.

Magrì D, Agostoni P, Ricotta A, Pisani L, Cauti FM, Onofri A, Bruno P, Ricci A, Volpe M, Marchitti S, Mariotta S, Rubattu S.

Eur J Intern Med. 2013 Apr;24(3):278-84. doi: 10.1016/j.ejim.2012.12.010. Epub 2013 Jan 5.

PMID:
23294508
37.

[Depression. A symbolic archetypal psychopathology].

Onofri A.

Vertex. 2012 May-Jun;23(103):205-11. Spanish.

PMID:
23145375
38.

Preoperative quality of life predicts survival following pulmonary resection in stage I non-small-cell lung cancer.

Pompili C, Salati M, Refai M, Berardi R, Onofri A, Mazzanti P, Brunelli A.

Eur J Cardiothorac Surg. 2013 May;43(5):905-10. doi: 10.1093/ejcts/ezs532. Epub 2012 Oct 22.

PMID:
23091229
39.

Resected biliary tract cancers: a novel clinical-pathological score correlates with global outcome.

Berardi R, Mocchegiani F, Pierantoni C, Federici A, Nicolini D, Morgese F, Onofri A, Risaliti A, Vivarelli M, Cascinu S.

Dig Liver Dis. 2013 Jan;45(1):70-4. doi: 10.1016/j.dld.2012.08.012. Epub 2012 Sep 19.

PMID:
22999058
40.

Response surface methodology as optimization strategy for asymmetric bioreduction of (4S)-(+)-carvone by Cryptococcus gastricus.

Goretti M, Branda E, Turchetti B, Cramarossa MR, Onofri A, Forti L, Buzzini P.

Bioresour Technol. 2012 Oct;121:290-7. doi: 10.1016/j.biortech.2012.06.070. Epub 2012 Jun 30.

PMID:
22858498
41.

Extracorporeal membrane oxygenation in a 10-year-old girl with macrophage activation syndrome.

Rossetti E, Bianchi R, Chiusolo F, Onofri A, Picardo S.

Paediatr Anaesth. 2012 Sep;22(9):937-8. doi: 10.1111/j.1460-9592.2012.03909.x. No abstract available.

PMID:
22834471
42.

Diagnostic value of conjunctival swab sampling associated with nested PCR for different categories of dogs naturally exposed to Leishmania infantum infection.

Di Muccio T, Veronesi F, Antognoni MT, Onofri A, Piergili Fioretti D, Gramiccia M.

J Clin Microbiol. 2012 Aug;50(8):2651-9. doi: 10.1128/JCM.00558-12. Epub 2012 May 30.

43.

[EMDR in Psychiatry. Introduction to the Supplement].

Onofri A.

Riv Psichiatr. 2012 Mar-Apr;47(2 Suppl):1-3. doi: 10.1708/1071.11730. Italian.

PMID:
22622271
44.

Maspin expression is a favorable prognostic factor in non-small cell lung cancer.

Berardi R, Santinelli A, Onofri A, Brunelli A, Pierantoni C, Pisa E, Pagliacci A, Stramazzotti D, Zuccatosta L, Mazzanti P, Sabbatini A, Gasparini S, Bearzi I, Cascinu S.

Anal Quant Cytol Histol. 2012 Apr;34(2):72-8.

PMID:
22611762
45.

Performance at preoperative stair-climbing test is associated with prognosis after pulmonary resection in stage I non-small cell lung cancer.

Brunelli A, Pompili C, Berardi R, Mazzanti P, Onofri A, Salati M, Cascinu S, Sabbatini A.

Ann Thorac Surg. 2012 Jun;93(6):1796-800. doi: 10.1016/j.athoracsur.2012.02.068. Epub 2012 May 1.

PMID:
22551844
46.

A novel approach to manage skin toxicity caused by therapeutic agents targeting epidermal growth factor receptor.

Campanati A, Berardi R, Onofri A, Pierantoni C, Conte I, Giuliodori K, Molinelli E, Marcucci F, Cascinu S, Offidani A.

Ann Oncol. 2012 Apr;23(4):1081-2. doi: 10.1093/annonc/mds026. No abstract available.

PMID:
22457259
47.

Nuclear factor-κB predicts outcome in locally advanced rectal cancer patients receiving neoadjuvant radio-chemotherapy.

Berardi R, Maccaroni E, Mandolesi A, Mantello G, Onofri A, Biscotti T, Pierantoni C, Siquini W, Marmorale C, Guerrieri M, Bearzi I, Cascinu S.

Dig Liver Dis. 2012 Jul;44(7):617-22. doi: 10.1016/j.dld.2012.02.006. Epub 2012 Mar 21.

PMID:
22440241
48.

Twice-daily dosing of temozolomide in combination with fotemustine for the treatment of patients with refractory glioblastoma.

Santoni M, Paccapelo A, Burattini L, Onofri A, Cascinu S.

Anticancer Res. 2012 Mar;32(3):1099-101.

PMID:
22399639
49.

Use of tyrosine kinase inhibitors in patients with metastatic kidney cancer receiving haemodialysis: a retrospective Italian survey.

Masini C, Sabbatini R, Porta C, Procopio G, Di Lorenzo G, Onofri A, Buti S, Iacovelli R, Invernizzi R, Moscetti L, Aste MG, Pagano M, Grosso F, Lucia Manenti A, Ortega C, Cosmai L, Del Giovane C, Conte PF.

BJU Int. 2012 Sep;110(5):692-8. doi: 10.1111/j.1464-410X.2012.10946.x. Epub 2012 Feb 24.

50.

Epidermal growth factor receptor status in stages of resected non-small cell lung cancer: implications for treatment with epidermal growth factor receptor inhibitors.

Berardi R, Santinelli A, Brunelli A, Onofri A, Pierantoni C, Scartozzi M, Pisa E, Stramazzotti D, Mazzanti P, Zuccatosta L, Gasparini S, Sabbatini A, Cascinu S.

Anal Quant Cytol Histol. 2011 Aug;33(4):196-204.

PMID:
21980623

Supplemental Content

Loading ...
Support Center